Gastrointestinal Cancer

Top Story

Chemoradiotherapy does not prolong OS in locally advanced pancreatic cancer

Chemoradiotherapy does not prolong OS in locally advanced pancreatic cancer
May 4, 2016

The addition of radiation to chemotherapy failed to improve OS for patients with locally advanced pancreatic cancer, according to the results of the randomized, open-label, phase 3 LAP07 trial.

Further, the addition of erlotinib (Tarceva; Genentech, Astellas Oncology) to gemcitabine also did not extend OS.

Radiopaque bead treatment at Mount Sinai ‘potential game-changer’ for hepatocellular carcinoma

May 3, 2016
An estimated 746,000 deaths occur annually from liver cancer worldwide.Few surgical options are considered beneficial in patients with intermediate- or advanced-stage…
Meeting News Coverage

Nucleos(t)ide therapy for HBV does not increase risk for all cancers

May 3, 2016
BARCELONA — New data presented at the International Liver Congress showed patients with chronic hepatitis B virus infection who receive long-term treatment with…
Meeting News CoverageVideo

VIDEO: Entrectinib safely, effectively treats gene-mutated cancers

May 2, 2016
NEW ORLEANS — Alexander Drilon, MD, assistant attending physician with the developmental therapeutics clinic and thoracic oncology service at Memorial Sloan…
CME

The Patient with Severe Leukocytosis

No commercial support for this activity.

Currently five tyrosine kinase inhibitors are available for use in patients with chronic myeloid leukemia (CML)…
More »
Video

VIDEO: Jimmy J. Hwang, MD, reviews factors involved in the prevention of colorectal cancer

April 26, 2016
More »
Featured
CME

The Patient with Multiple Ecchymoses

No commercial support for this activity.

Glanzmann’s thrombasthenia is a rare, inherited bleeding disorder that results from a mutation in αIIbß3, an integrin…
More »
In the Journals

Chemoradiotherapy does not prolong OS in locally advanced pancreatic cancer

May 4, 2016
The addition of radiation to chemotherapy failed to improve OS for patients with locally advanced pancreatic cancer, according to the results of the…

Radiopaque bead treatment at Mount Sinai ‘potential game-changer’ for hepatocellular carcinoma

May 3, 2016
An estimated 746,000 deaths occur annually from liver cancer worldwide.Few surgical options are considered beneficial in patients with intermediate-…
Meeting News Coverage

Nucleos(t)ide therapy for HBV does not increase risk for all cancers

May 3, 2016
BARCELONA — New data presented at the International Liver Congress showed patients with chronic hepatitis B virus infection who receive…
Meeting News CoverageVideo

VIDEO: Entrectinib safely, effectively treats gene-mutated cancers

May 2, 2016
NEW ORLEANS — Alexander Drilon, MD, assistant attending physician with the developmental therapeutics clinic and thoracic oncology service at…

Indiana University Health Simon Cancer Center yoga program eases stress associated with diagnosis, treatment

May 2, 2016
Yoga therapy is an integrative medicine technique that supplements the traditional treatment regimens patients with cancer undergo.A patient’s…
In the Journals

Endoscopic biopsy, EUS inadequate for detecting residual esophageal cancer after neoadjuvant chemoradiotherapy

May 2, 2016
Endoscopic biopsy and endoscopic ultrasound did not perform with sufficient accuracy in detecting pathologic complete response in patients with…
Meeting News CoverageVideo

VIDEO: New approaches demonstrate potential to exploit immune system to treat cancer

April 30, 2016
NEW ORLEANS — Kunle Odunsi, MD, PhD, FRCOG, FACOG, deputy director of Roswell Park Cancer Institute and executive director of the…
In the Journals

CT colonography comparable to flexible sigmoidoscopy for CRC screening

April 29, 2016
CT colonography performed with a comparable detection rate to flexible sigmoidoscopy as a screening test for colorectal cancer in two randomized…
In the Journals

Fewer blood transfusions used for major oncologic abdominal surgery

April 29, 2016
Fewer perioperative blood transfusions have occurred for oncologic abdominal surgery over the last 9 years, according to results of a retrospective…
In the Journals

Monthly cost of oral cancer drugs rises steadily over time

April 28, 2016
The cost of oral cancer drugs in their first year on the market has increased significantly since the year 2000, according to a research letter…
More Headlines »